Shares of Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) rose 1.2% during mid-day trading on Thursday . The stock traded as high as $0.98 and last traded at $0.98. Approximately 200 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 5,616 shares. The stock had previously closed at $0.9680.
Avacta Group Stock Performance
The company has a 50 day simple moving average of $1.01 and a 200 day simple moving average of $0.71.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- Golden Cross Stocks: Pattern, Examples and Charts
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- What Are Growth Stocks and Investing in Them
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- Roth IRA Calculator: Calculate Your Potential Returns
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
